Earlier this year, Seralite® – FLC Serum was granted registration by the Brazilian Health Regulatory Agency (ANVISA).
Seralite® – FLC is a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains (FLCs) in serum. Seralite® – FLC was developed by Abingdon Health and is manufactured at Abingdon Health's ISO and GMP compliant facility.
With this registration in Brazil, Seralite® – FLC is now available in 73 countries worldwide. Seralite® – FLC is distributed globally (with the exception of Benelux), by Sebia, the world leader in medical diagnostics for electrophoresis.About Abingdon Health
Abingdon Health is a unique end-to-end service provider for low to high volume lateral flow assay manufacturing while also offering, where required, desktop and smartphone reader customisation. In addition to these capabilities, we are able to offer long-term regulatory and commercial assistance as well as adopt legal manufacturer status to expedite product market entry.